Literature DB >> 16410527

Responsiveness of the shoulder function assessment scale in patients with rheumatoid arthritis.

H M Vermeulen1, F C Breedveld, S Le Cessie, P M Rozing, C H M van den Ende, T P M Vliet Vlieland.   

Abstract

OBJECTIVES: To investigate the responsiveness of the Shoulder Function Assessment scale (SFA) in patients with rheumatoid arthritis (RA).
METHODS: In 35 patients with RA receiving a (peri-)articular injection because of local shoulder complaints the SFA, impact of shoulder function on activities of daily living, active shoulder range of motion (ROM), the 28 joint count Disease Activity Score (DAS28), and the Health Assessment Questionnaire (HAQ) were measured before and 4-6 weeks after treatment. Responsiveness was determined using the standardised response mean (SRM), effect size (ES), and responsiveness ratio (RR).
RESULTS: Overall, significant improvement was seen according to the SFA (mean change 10.9 (95% confidence interval 6.5 to 15.3)), active shoulder ROM (except external rotation), and the impact of shoulder function on daily activities. In addition, the DAS28 and HAQ scores improved significantly. The responsiveness of the SFA was excellent, with the SRM, ES, and RR being -0.86, -1.16, and 1.28, respectively.
CONCLUSIONS: In addition to its good validity and reliability, the SFA proved to have a high sensitivity to clinical changes in patients with RA who received local treatment for shoulder complaints.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410527      PMCID: PMC1798022          DOI: 10.1136/ard.2005.036236

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

1.  Measuring clinically important changes with patient-oriented questionnaires.

Authors:  Matthew H Liang; Robert A Lew; Gerold Stucki; Paul R Fortin; Lawren Daltroy
Journal:  Med Care       Date:  2002-04       Impact factor: 2.983

2.  Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors:  A Larsen; K Dale; M Eek
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-07

3.  Measuring change over time: assessing the usefulness of evaluative instruments.

Authors:  G Guyatt; S Walter; G Norman
Journal:  J Chronic Dis       Date:  1987

4.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

Review 6.  Evaluating the outcome of treatment. Shouldn't We be asking patients if they are better?

Authors:  J G Wright
Journal:  J Clin Epidemiol       Date:  2000-06       Impact factor: 6.437

7.  Assessment of shoulder function in rheumatoid arthritis.

Authors:  C H van Den Ende; P M Rozing; B A Dijkmans; J A Verhoef; E M Voogt-van der Harst; J M Hazes
Journal:  J Rheumatol       Date:  1996-12       Impact factor: 4.666

8.  Comparisons of five health status instruments for orthopedic evaluation.

Authors:  M H Liang; A H Fossel; M G Larson
Journal:  Med Care       Date:  1990-07       Impact factor: 2.983

9.  Measurement of disability in Dutch rheumatoid arthritis patients.

Authors:  C E Siegert; L J Vleming; J P Vandenbroucke; A Cats
Journal:  Clin Rheumatol       Date:  1984-09       Impact factor: 2.980

  9 in total
  1 in total

1.  Intra articular injection with corticosteroids in patients with recent onset rheumatoid arthritis: subanalyses from the BeSt study.

Authors:  Emilia Gvozdenović; Linda Dirven; Marianne van den Broek; K Huub Han; Esmeralda T H Molenaar; Robert B M Landewé; Willem F Lems; Cornelia F Allaart
Journal:  Clin Rheumatol       Date:  2014-01-03       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.